|

mFOLFOX6 Regimen (Oxaliplatin/Leucovorin/5-FU) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Haisco Pharmaceutical Group Co., Ltd.1

Indications

  • Metastatic Colorectal Cancer (CRC)1
  • Cancer1

Other1 trial

HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.